olmesartan has been researched along with Apnea, Sleep in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, T; Inoshita, A; Ishiwata, S; Kasagi, S; Kasai, T; Maeno, K; Momomura, S; Narui, K; Ohno, M; Takaya, H; Yamaguchi, T | 1 |
| Inoue, H; Nakamura, Y; Nishijima, T; Sakurai, S; Takahashi, S | 1 |
2 other study(ies) available for olmesartan and Apnea, Sleep
| Article | Year |
|---|---|
Effects of olmesartan on blood pressure and insulin resistance in hypertensive patients with sleep-disordered breathing.
Topics: Adult; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Female; Humans; Hypertension; Imidazoles; Insulin; Insulin Resistance; Japan; Male; Middle Aged; Pilot Projects; Prospective Studies; Sleep Apnea Syndromes; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Function, Left | 2011 |
Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome.
Topics: Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Female; Gene Expression Regulation; Humans; Imidazoles; Leukocytes; Male; Middle Aged; Neutrophils; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sleep Apnea Syndromes; Tetrazoles; Vascular Endothelial Growth Factor A | 2005 |